Neuphoria Therapeutics (NEUP) EBT (2023 - 2026)
Neuphoria Therapeutics (NEUP) posted quarterly EBT of -$539856.0 for Q1 2026, down 104.83% year-over-year from $11.2 million in Q1 2025, and down 129.51% quarter-over-quarter from $1.8 million in Q4 2025.
Neuphoria Therapeutics (NEUP) EBT (2023 - 2026) Analysis & Trends
Neuphoria Therapeutics (NEUP) has reported EBT for 4 consecutive years, with -$539856.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT fell 104.83% year-over-year to -$539856.0; the TTM figure through Mar 2026 stood at -$10.7 million (down 291.21% YoY), while the FY2025 annual figure was $6.3 million, up 140.27% from the prior year.
- EBT slipped to -$539856.0 in Q1 2026 per NEUP's latest filing, from $1.8 million in the prior quarter.
- Across five years, EBT topped out at $11.2 million in Q1 2025 and bottomed at -$9.9 million in Q3 2025.
- Historically, EBT has averaged -$1.6 million across 4 years, with a median of -$2.0 million in 2025.
- On a YoY basis, EBT climbed as much as 504.85% in 2025 and fell as far as 961.0% in 2025.
- Neuphoria Therapeutics' EBT stood at -$4.6 million in 2023, then soared by 57.91% to -$1.9 million in 2024, then surged by 194.7% to $1.8 million in 2025, then plunged by 129.51% to -$539856.0 in 2026.
- Business Quant data shows NEUP's EBT at -$539856.0 in Q1 2026, $1.8 million in Q4 2025, and -$9.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Neuphoria Therapeutics | 21.37 Mn | 1.93 Mn | - | -539,856.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -539,856.00 |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | -9.94 Mn |
| Jun 30, 2025 | -2.04 Mn |
| Mar 31, 2025 | 11.18 Mn |
| Dec 31, 2024 | -1.93 Mn |
| Sep 30, 2024 | -936,974.00 |
| Jun 30, 2024 | -2.72 Mn |
| Mar 31, 2024 | -2.76 Mn |
| Dec 31, 2023 | -4.59 Mn |
| Sep 30, 2023 | -5.51 Mn |